Veterinary Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022
[161 Pages Report] The veterinary vaccines market is expected to reach USD 8.66 Billion by 2022 from USD 6.08 Billion in 2016 at a CAGR of 5.9%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022.
Research Methodology: Veterinary Vaccines Market Research
Top-down and bottom-up approaches were used to validate the size of the global veterinary vaccines market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources referred to are World Society for the Protection of Animals, Animal Health Institute, American Pet Products Association, World Organisation for Animal Health, Department of Livestock Development, Ministry of Agriculture and Cooperatives, Federation of Asian Veterinary Associations, and Thai Veterinary Medical Association.
To know about the assumptions considered for the study, download the pdf brochure
The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).
Target Audience for Veterinary Vaccines Market Research Report:
- Animal vaccines manufacturers
- Animal healthcare product manufacturers
- Animal vaccine distributors and wholesalers
- Animal welfare associations
- Veterinary clinics and care centers
Scope of the Veterinary Vaccines Market Research Report
The research report categorizes the global veterinary vaccines market into the following segments and subsegments:
Animal Vaccines Market by Type
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- Bovine Vaccines
- Small Ruminant Vaccines
- Companion Animal Vaccines
- Canine Vaccines
- Feline Vaccines
- Aquaculture Vaccines
- Other Animal Vaccines
Animal Vaccines Market by Disease
- Porcine Diseases
- Poultry Diseases
- Livestock Diseases
- Bovine Diseases
- Small Ruminant Diseases
- Companion Animal Diseases
- Canine Diseases
- Feline Diseases
- Aquaculture Diseases
- Other Diseases
Animal Vaccines Market by Technology
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Other Vaccines
Animal Vaccines Market by Region
- North America
- US
- Canada
- Europe
- Asia Pacific (APAC)
- China
- Thailand
- India
- Rest of APAC (RoAPAC)
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the European veterinary vaccines market into UK, France, Germany, Italy, Spain, and the Rest of Europe
- Further breakdown of the Rest of the World (RoW) veterinary vaccines market into Brazil, Mexico, Argentina, and Rest of the RoW
- Animal Vaccines Market by volume
The global veterinary vaccines market is projected to reach USD 8.66 Billion by 2022 from USD 6.50 Billion in 2017, at a CAGR of 5.9% during the forecast period (2017-2022). The major factors driving the growth of this market include growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines.
By type, the market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines and other vaccines. The livestock vaccines are further divided into two major categories on the basis of the type of animal, namely, bovine vaccines and small ruminant vaccines. Similarly, companion animal vaccines are divided into two segments, namely, canine animal vaccines and feline animal vaccines. In 2017, porcine vaccines segment is expected to account for the largest share of the global veterinary vaccines market, in terms of value. Whereas, the companion animal vaccines segment is expected to register the highest growth rate due to increasing awareness about companion animal vaccination, rising prevalence of zoonotic diseases in humans, and the growing number of pets, and increasing pet ownership.
By disease, the animal vaccines market is classified into poultry diseases, porcine diseases, livestock diseases (bovine diseases and small ruminant diseases), companion animal diseases (canine diseases and feline diseases), and aquaculture diseases. The porcine disease segment is expected to account for the largest share of the animal vaccines market during the forecast period.
The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology. The live attenuated vaccines segment is expected to account for the largest share of the veterinary vaccines market in 2017. The ease of administration and long-term immunity offered by live attenuated vaccines are factors driving the adoption of this technology.
In 2017, in terms of value, Europe is expected to account for the largest share of the global market, followed by North America. However, the Asia Pacific region is expected to register the highest growth during the forecast period. Rising pet adoption, expansion of key players in the region, a wide range of product launches, and investments in vaccine manufacturing facilities, especially in India, China, and Thailand, are driving the growth of this regional segment.
Factors such as high storage cost for vaccines is expected to restrain animal vaccines market growth to a certain extent.
The key players in the veterinary vaccines market include Zoetis (US), Merck Animal Health (US), Elanco Animal Health (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Veterinary Vaccines Market: Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Veterinary Vaccines Market: Research Methodology (Page No. - 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primary Interviews
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Research Assumptions
3 Veterinary Vaccines Market: Executive Summary (Page No. - 25)
4 Veterinary Vaccines Market: Premium Insights (Page No. - 28)
4.1 Global Market Overview
4.2 APAC Market, By Technology and Region
4.3 Poultry Animal Market, By Disease
4.4 Market By Geography
5 Veterinary Vaccines Market: Overview (Page No. - 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growth in Livestock Population and Repeated Outbreaks of Livestock Diseases
5.2.1.2 Increasing Adoption of Companion Animals
5.2.1.3 Rising Incidence of Zoonotic Diseases
5.2.1.4 Initiatives By Various Government Agencies, Animal Associations, and Leading Players
5.2.1.5 Introduction of New Types of Vaccines
5.2.2 Restraints
5.2.2.1 High Storage Costs for Vaccines
5.2.3 Opportunities
5.2.3.1 Technological Advancements
5.2.3.2 Growing Awareness of Animal Health in Emerging Economies
5.2.4 Challenge
5.2.4.1 Inadequate Surveillance and Reporting Systems
6 Veterinary Vaccines Market By Type (Page No. - 38)
6.1 Introduction
6.2 Porcine Vaccines
6.3 Poultry Vaccines
6.4 Livestock Vaccines
6.4.1 Bovine Vaccines
6.4.2 Small Ruminant Vaccines
6.5 Companion Animal Vaccines
6.5.1 Canine Vaccines
6.5.2 Feline Vaccines
6.6 Aquaculture Vaccines
6.7 Other Animal Vaccines
7 Veterinary Vaccines Market By Disease (Page No. - 54)
7.1 Introduction
7.2 Porcine
7.3 Poultry
7.4 Livestock
7.4.1 Bovine
7.4.2 Small Ruminants
7.5 Companion Animals
7.5.1 Canine
7.5.2 Feline
7.6 Aquaculture
8 Veterinary Vaccines Market By Technology (Page No. - 69)
8.1 Introduction
8.2 Live Attenuated Vaccines
8.3 Inactivated Vaccines
8.4 Toxoid Vaccines
8.5 Recombinant Vaccines
8.6 Other Vaccines
9 Veterinary Vaccines Market By Region (Page No. - 78)
9.1 Introduction
9.2 Europe
9.3 North America
9.3.1 US
9.3.2 Canada
9.4 Asia Pacific (APAC)
9.4.1 China
9.4.2 Thailand
9.4.3 India
9.4.4 Rest of APAC
9.5 Rest of the World
10 Veterinary Vaccines Market: Competitive Landscape (Page No. - 113)
10.1 Introduction
10.2 Market Ranking Analysis
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Benchmarking
10.4.1 Strength of Product Portfolio (25 Players)
10.4.2 Business Strategy Excellence (25 Players)
11 Veterinary Vaccines Market: Company Profiles (Page No. - 118)
11.1 Zoetis
11.1.1 Business Overview
11.1.2 Strength of Product Portfolio
11.1.3 Business Strategy Excellence
11.1.4 Recent Developments
11.2 Merck Animal Health
11.2.1 Business Overview
11.2.2 Strength of Product Portfolio
11.2.3 Business Strategy Excellence
11.2.4 Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Business Overview
11.3.2 Strength of Product Portfolio
11.3.3 Business Strategy Excellence
11.3.4 Recent Developments
11.4 Elanco
11.4.1 Business Overview
11.4.2 Strength of Product Portfolio
11.4.3 Business Strategy Excellence
11.4.4 Recent Developments
11.5 Ceva
11.5.1 Business Overview
11.5.2 Strength of Product Portfolio
11.5.3 Business Strategy Excellence
11.5.4 Recent Developments
11.6 Virbac
11.6.1 Business Overview
11.6.2 Strength of Product Portfolio
11.6.3 Business Strategy Excellence
11.6.4 Recent Developments
11.7 Vetoquinol
11.7.1 Business Overview
11.7.2 Vetoquinol: Company Snapshot (2016)
11.7.3 Strength of Product Portfolio
11.7.4 Business Strategy Excellence
11.7.5 Recent Developments
11.8 Phibro Animal Health
11.8.1 Business Overview
11.8.2 Phibro Animal Health: Company Snapshot (2016)
11.8.3 Strength of Product Portfolio
11.8.4 Business Strategy Excellence
11.8.5 Recent Developments
11.9 Hester
11.9.1 Business Overview
11.9.2 Hester: Company Snapshot (2016)
11.9.3 Strength of Product Portfolio
11.9.4 Business Strategy Excellence
11.9.5 Recent Developments
11.10 Hipra
11.10.1 Business Overview
11.10.2 Strength of Product Portfolio
11.10.3 Business Strategy Excellence
11.10.4 Recent Developments
11.11 Idt Biologika
11.11.1 Business Overview
11.11.2 Strength of Product Portfolio
11.11.3 Business Strategy Excellence
11.11.4 Recent Developments
11.12 Biogenesis Bago
11.12.1 Business Overview
11.12.2 Strength of Product Portfolio
11.12.3 Business Strategy Excellence
11.13 Tianjin Ringpu
11.13.1 Business Overview
11.13.2 Strength of Product Portfolio
11.13.3 Business Strategy Excellence
11.14 China Animal Husbandry
11.14.1 Business Overview
11.14.2 Strength of Product Portfolio
11.14.3 Business Strategy Excellence
11.14.4 Recent Developments
11.15 Jinyu Bio-Technology
11.15.1 Business Overview
11.15.2 Strength of Product Portfolio
11.15.3 Business Strategy Excellence
12 Appendix (Page No. - 152)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (148 Tables)
Table 1 Global Livestock Animal Population, 2000 and 2013
Table 2 Animal Disease Outbreaks Reported in Recent Years
Table 3 Percentage of Pet Ownership, By Country, 2016
Table 4 Small Companion Animal Population, By Country, 2014 vs 2016 (Million)
Table 5 Market By Type, 20152022 (USD Million)
Table 6 Porcine Vaccines Market, By Region, 20152022 (USD Million)
Table 7 North America: Porcine Vaccines Market, By Country, 20152022 (USD Million)
Table 8 Asia Pacific: Porcine Vaccines Market, By Country, 20152022 (USD Million)
Table 9 Poultry Vaccines Market, By Region, 20152022 (USD Million)
Table 10 North America: Poultry Vaccines Market, By Country, 20152022 (USD Million)
Table 11 Asia Pacific: Poultry Vaccines Market, By Country, 20152022 (USD Million)
Table 12 Livestock Vaccines Market, By Region, 20152022 (USD Million)
Table 13 North America: Livestock Vaccines Market, By Country, 20152022 (USD Million)
Table 14 Asia Pacific: Livestock Vaccines Market, By Country, 20152022 (USD Million)
Table 15 Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 16 Bovine Vaccines Market, By Region, 20152022 (USD Million)
Table 17 North America: Bovine Vaccines Market, By Country, 20152022 (USD Million)
Table 18 Asia Pacific: Bovine Vaccines Market, By Country, 20152022 (USD Million)
Table 19 Small Ruminant Vaccines Market, By Region, 20152022 (USD Million)
Table 20 North America: Small Ruminant Vaccines Market, By Country, 20152022 (USD Million)
Table 21 Asia Pacific: Small Ruminant Vaccines Market, By Country, 20152022 (USD Million)
Table 22 Companion Animal Vaccines Market, By Region, 20152022 (USD Million)
Table 23 North America: Companion Animal Vaccines Market, By Country, 20152022 (USD Million)
Table 24 Asia Pacific: Companion Animal Vaccines Market, By Country, 20152022 (USD Million)
Table 25 Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 26 Canine Vaccines Market, By Region, 20152022 (USD Million)
Table 27 North America: Canine Vaccines Market, By Country, 20152022 (USD Million)
Table 28 Asia Pacific: Canine Vaccines Market, By Country, 20152022 (USD Million)
Table 29 Feline Vaccines Market, By Region, 20152022 (USD Million)
Table 30 North America: Feline Vaccines Market, By Country, 20152022 (USD Million)
Table 31 Asia Pacific: Feline Vaccines Market, By Country, 20152022 (USD Million)
Table 32 Aquaculture Vaccines Market, By Region, 20152022 (USD Million)
Table 33 North America: Aquaculture Vaccines Market, By Country, 20152022 (USD Million)
Table 34 Other Animal Vaccines Market, By Region, 20152022 (USD Million)
Table 35 North America: Other Animal Vaccines Market, By Country, 20152022 (USD Million)
Table 36 Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 37 Porcine Circovirus Ii Vaccines Market, By Region, 20152022 (USD Million)
Table 38 North America: Porcine Circovirus Ii Vaccines Market, By Country, 20152022 (USD Million)
Table 39 Asia Pacific: Porcine Circovirus Ii Vaccines Market, By Country, 20152022 (USD Million)
Table 40 Porcine Reproductive Respiratory Syndrome Vaccines Market, By Region, 20152022 (USD Million)
Table 41 North America: Porcine Reproductive Respiratory Syndrome Vaccines Market, By Country, 20152022 (USD Million)
Table 42 Asia Pacific: Porcine Reproductive Respiratory Syndrome Vaccines Market, By Country, 20152022 (USD Million)
Table 43 Porcine Parvovirus Vaccines Market, By Region, 20152022 (USD Million)
Table 44 North America: Porcine Parvovirus Vaccines Market, By Country, 20152022 (USD Million)
Table 45 Asia Pacific: Porcine Parvovirus Vaccines Market, By Country, 20152022 (USD Million)
Table 46 Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 47 Infectious Bronchitis Vaccines Market, By Region, 20152022 (USD Million)
Table 48 North America: Infectious Bronchitis Vaccines Market, By Country, 20152022 (USD Million)
Table 49 Asia Pacific: Infectious Bronchitis Vaccines Market, By Country, 20152022 (USD Million)
Table 50 Avian Influenza Vaccines Market, By Region, 20152022 (USD Million)
Table 51 North America: Avian Influenza Vaccines Market, By Country, 20152022 (USD Million)
Table 52 Asia Pacific: Avian Influenza Vaccines Market, By Country, 20152022 (USD Million)
Table 53 Newcastle Disease Vaccines Market, By Region, 20152022 (USD Million)
Table 54 North America: Newcastle Disease Vaccines Market, By Country, 20152022 (USD Million)
Table 55 Asia Pacific: Newcastle Disease Vaccines Market, By Country, 20152022 (USD Million)
Table 56 Bovine Vaccines Market, By Disease, 20152022 (USD Million)
Table 57 Foot-And-Mouth Disease Vaccines Market, By Region, 20152022 (USD Million)
Table 58 Bovine Viral Diarrhea Vaccines Market, By Region, 20152022 (USD Million)
Table 59 Bovine Clostridial Disease Vaccines Market, By Region, 20152022 (USD Million)
Table 60 Brucellosis Vaccines Market, By Region, 20152022 (USD Million)
Table 61 Small Ruminant Vaccines Market, By Disease, 20152022 (USD Million)
Table 62 Canine Vaccines Market, By Disease, 20152022 (USD Million)
Table 63 Feline Vaccines Market, By Disease, 20152022 (USD Million)
Table 64 Aquaculture Vaccines Market, By Disease, 20152022 (USD Million)
Table 65 Veterinary Vaccines Market, By Technology, 20152022 (USD Million)
Table 66 Live Attenuated Vaccines Market, By Region, 20152022 (USD Million)
Table 67 North America: Live Attenuated Vaccines Market, By Country, 20152022 (USD Million)
Table 68 Asia Pacific: Live Attenuated Vaccines Market, By Country, 20152022 (USD Million)
Table 69 Inactivated Vaccines Market, By Region, 20152022 (USD Million)
Table 70 North America: Inactivated Vaccines Market, By Country, 20152022 (USD Million)
Table 71 Asia Pacific: Inactivated Vaccines Market, By Country, 20152022 (USD Million)
Table 72 Toxoid Vaccines Market, By Region, 20152022 (USD Million)
Table 73 North America: Toxoid Vaccines Market, By Country, 20152022 (USD Million)
Table 74 Asia Pacific: Toxoid Vaccines Market, By Country, 20152022 (USD Million)
Table 75 Recombinant Vaccines Market, By Region, 20152022 (USD Million)
Table 76 North America: Recombinant Vaccines Market, By Country, 20152022 (USD Million)
Table 77 Asia Pacific: Recombinant Vaccines Market, By Country, 20152022 (USD Million)
Table 78 Other Vaccines Market, By Region, 20152022 (USD Million)
Table 79 North America: Other Vaccines Market, By Country, 20152022 (USD Million)
Table 80 Asia Pacific: Other Vaccines Market, By Country, 20152022 (USD Million)
Table 81 Animal Vaccines Market, By Region, 20152022 (USD Million)
Table 82 Europe: Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 83 Europe: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 84 Europe: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 85 Europe: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 86 Europe: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 87 Europe: Bovine Vaccines Market, By Disease, 20152022 (USD Million)
Table 88 Europe: Veterinary Vaccines Market, By Technology, 20152022 (USD Million)
Table 89 North America: Global Market By Type, 20152022 (USD Million)
Table 90 North America: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 91 North America: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 92 North America: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 93 North America: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 94 North America: Bovine Vaccines Market, By Disease, 20152022 (USD Million)
Table 95 North America: Global Market By Technology, 20152022 (USD Million)
Table 96 North America: Global Market By Country, 20152022 (USD Million)
Table 97 US: Global Market By Type, 20152022 (USD Million)
Table 98 US: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 99 US: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 100 US: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 101 US: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 102 US: Veterinary Vaccines Market, By Technology, 20152022 (USD Million)
Table 103 Canada: Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 104 Canada: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 105 Canada: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 106 Canada: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 107 Canada: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 108 Canada: Animal Vaccines Market, By Technology, 20152022 (USD Million)
Table 109 Asia Pacific: Veterinary Vaccines Market, By Type, 20152022 (USD Million)
Table 110 Asia Pacific: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 111 Asia Pacific: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 112 Asia Pacific: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 113 Asia Pacific: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 114 Asia Pacific: Bovine Vaccines Market, By Disease, 20152022 (USD Million)
Table 115 Asia Pacific: Global Market By Technology, 20152022 (USD Million)
Table 116 Asia Pacific: Global Market By Country, 20152022 (USD Million)
Table 117 China: Veterinary Vaccines Market, By Type, 20152022 (USD Million)
Table 118 China: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 119 China: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 120 China: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 121 China: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 122 China: Animal Vaccines Market, By Technology, 20152022 (USD Million)
Table 123 Thailand: Veterinary Vaccines Market, By Type, 20152022 (USD Million)
Table 124 Thailand: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 125 Thailand: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 126 Thailand: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 127 Thailand: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 128 Thailand: Global Market By Technology, 20152022 (USD Million)
Table 129 India: Veterinary Vaccines Market, By Type, 20152022 (USD Million)
Table 130 India: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 131 India: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 132 India: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 133 India: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 134 India: Global Market By Technology, 20152022 (USD Million)
Table 135 RoAPAC: Veterinary Vaccines Market, By Type, 20152022 (USD Million)
Table 136 RoAPAC: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 137 RoAPAC: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 138 RoAPAC: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 139 RoAPAC: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 140 RoAPAC: Global Market By Technology, 20152022 (USD Million)
Table 141 RoW: Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 142 RoW: Livestock Vaccines Market, By Type, 20152022 (USD Million)
Table 143 RoW: Companion Animal Vaccines Market, By Type, 20152022 (USD Million)
Table 144 RoW: Porcine Vaccines Market, By Disease, 20152022 (USD Million)
Table 145 RoW: Poultry Vaccines Market, By Disease, 20152022 (USD Million)
Table 146 RoW: Bovine Vaccines Market, By Disease, 20152022 (USD Million)
Table 147 RoW: Veterinary Vaccines Market, By Technology, 20152022 (USD Million)
Table 148 Rank of Companies in the Veterinary Vaccines Market, 2017
List of Figures (26 Figures)
Figure 1 Research Design: Animal Vaccines Market
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Market Data Triangulation Methodology
Figure 6 Global Market By Type, 2017 vs 2022
Figure 7 Global Market By Technology, 2017 vs 2022
Figure 8 Porcine Vaccines Market, By Disease, 2017 vs 2022
Figure 9 Veterinary Vaccines Market, By Region
Figure 10 Growth in Livestock Population and Repeated Breakouts of Livestock Diseases are Driving the Veterinary Vaccines Market
Figure 11 Live Attenuated Vaccines Segment is Estimated to Account for the Largest Share of the Market in 2017
Figure 12 Infectious Bronchitis Segment to Account for the Largest Share for Animal Vaccines Market in 2017 and 2022
Figure 13 APAC is Expected to Have the Fastest CAGR During the Forecast Period
Figure 14 Market Drivers, Restraints, Opportunities, and Challenges
Figure 15 Porcine Vaccines Segment to Dominate the Global Market in 2017
Figure 16 Live Attenuated Vaccines Segment to Dominate the Global Market in 2022
Figure 17 Geographic Snapshot: Asia Pacific to Witness the Highest Growth in the Forecast Period
Figure 18 Europe: Global Market Snapshot
Figure 19 Asia Pacific: Global Market Snapshot
Figure 20 Animal Vaccines Market (Global), Competitive Leadership Mapping, 2017
Figure 21 Zoetis: Company Snapshot (2016)
Figure 22 Merck & Co. Inc.: Company Snapshot (2016)
Figure 23 Boehringer Ingelheim: Company Snapshot (2016)
Figure 24 Elanco: Company Snapshot (2016)
Figure 25 Ceva: Company Snapshot (2016)
Figure 26 Virbac: Company Snapshot (2016)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Veterinary Vaccines Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Veterinary Vaccines Market